Today, the Centers
for Medicare & Medicaid Services (CMS) released a manufacturer release
(Release No. 113) to address how manufacturers can ensure they are
complying with reporting obligation and requirements of the Medicaid Drug
Rebate Program for their covered outpatient drugs. CMS is providing this
guidance to ensure that manufactures can determine if they are correctly
reporting their data and describes some of the steps that manufacturers
should take if corrections are required.
Upon entering the
program, and each month and quarter thereafter, manufacturers must report
certain pricing and product data to CMS to meet statutory and regulatory
requirements for participation. This data help to determine the rebates
that manufacturers pay to states for prescription drugs provided to state
Medicaid beneficiaries.
|
No comments:
Post a Comment